Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The effects of awareness, treatment and control of hypertension on cardiovascular and all-cause mortality in a community-based population

Journal of Human Hypertension volume 23, pages 808–816 (2009)Cite this article

Abstract

The objective of this prospective follow-up study (median follow-up time 20 years) was to investigate whether there are differences in cardiovascular disease (CVD) and all-cause mortality among hypertensive men and women by awareness, treatment and blood pressure (BP) control status. The study was carried out among 20 358 men and 21 537 women aged 25–64 years living in Eastern and south-western Finland within the framework of the North Karelia Project and the Finrisk studies. Risk factors of CVD and life-style habits were assessed by a self-administered questionnaire, BP and laboratory measurements. The participants were classified into five groups according to their BP status: (i) normotensive, (ii) patients treated with antihypertensive drugs and controlled for HT, (iii) patients treated with antihypertensive drugs but uncontrolled for HT, (iv) hypertensive people aware of their HT but untreated, (v) hypertensive people unaware of their hypertension (HT). In men, all-cause and CVD mortality was significantly higher in all HT subgroups compared with the normotensive group. The risk increase for CVD mortality was 49–125% and 27–79% for all-cause mortality, respectively. Treated and controlled hypertensive women at baseline did not have any increase in CVD (hazard ratio (HR) 1.14; 95% CI 0.89–1.46) or all-cause mortality (HR 1.09; 95% CI 0.72–1.67) compared with normotensive women. In men, however, the corresponding HR were 1.58 (95% CI 1.28–1.96) for CVD and 2.25 (95% CI 1.70–2.99) for all-cause mortality. Treated hypertensive women seem to benefit from achieving normal BP.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA et al. Blood pressure, stroke and coronary heart disease. Part 2: short term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–839.

    Article  CAS  Google Scholar 

  2. Boudik F, Reissigova J, Hrach K, Tomeckova M, Bultas J, Anger Z et al. Primary prevention of coronary artery disease among middle aged men in Prague: twenty-year follow-up results. Atherosclerosis 2006; 184: 86–93.

    Article  CAS  Google Scholar 

  3. Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A . Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens 2006; 24: 423–430.

    Article  CAS  Google Scholar 

  4. Gueyffier F, Boutitie F, Boissel JP, Pocock S, Coope J, Cutler J et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med 1997; 126: 761–767.

    Article  CAS  Google Scholar 

  5. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997; 277: 739–745.

    Article  CAS  Google Scholar 

  6. Almgren T, Persson B, Wilhelmsen L, Rosengren A, Andersson OK . Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades. J Intern Med 2005; 257: 496–502.

    Article  CAS  Google Scholar 

  7. Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K et al. The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J 1986; 7: 279–288.

    Article  CAS  Google Scholar 

  8. Andersson OK, Almgren T, Persson B, Samuelsson O, Hedner T, Wilhelmsen L . Survival in treated hypertension: follow up study after two decades. BMJ 1998; 317: 167–171.

    Article  CAS  Google Scholar 

  9. Clausen J, Jensen G . Blood pressure and mortality: an epidemiological survey with 10 years follow-up. J Hum Hypertens 1992; 6: 53–59.

    CAS  PubMed  Google Scholar 

  10. Gudmundsson LS, Johannsson M, Thorgeirsson G, Sigfusson N, Sigvaldason H, Witteman JC . Hypertension control as predictor of mortality in treated men and women, followed for up to 30 years. Cardiovasc Drugs Ther 2005; 19: 227–235.

    Article  Google Scholar 

  11. Casiglia E, Mazza A, Tikhonoff V, Pessina AC . Population-based studies improve outcome in hypertensive patients. Am J Hypertens 2002; 15: 605–608.

    Article  Google Scholar 

  12. Bulpitt CJ, Palmer AJ, Fletcher AE, Beevers DG, Coles EC, Ledingham JG et al. Optimal blood pressure control in treated hypertensive patients. Report from the Department of Health Hypertension Care Computing Project (DHCCP). Circulation 1994; 90: 225–233.

    Article  CAS  Google Scholar 

  13. Trafford JA, Horn CR, O'Neal H, McGonigle R, Halford-Maw L, Evans R . Five year follow-up of effects of treatment of mild and moderate hypertension. Br Med J (Clin Res Ed) 1981; 282: 1111–1113.

    Article  CAS  Google Scholar 

  14. Benetos A, Thomas F, Bean K, Gautier S, Smulyan H, Guize L . Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch Intern Med 2002; 162: 577–581.

    Article  Google Scholar 

  15. Harms LM, Schellevis FG, van Eijk JT, Donker AJ, Bouter LM . Cardiovascular morbidity and mortality among hypertensive patients in general practice: the evaluation of long-term systematic management. J Clin Epidemiol 1997; 50: 779–786.

    Article  CAS  Google Scholar 

  16. Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P . Cardiovascular risk factor changes in Finland, 1972–1997. Int J Epidemiol 2000; 29: 49–56.

    Article  CAS  Google Scholar 

  17. WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988; 41: 105 14.

    Article  Google Scholar 

  18. Tuomilehto J, Vartiainen E, Sarti C, Nissinen A, Kastarinen M . Trends in hypertension, cardiovascular risk and stroke mortality in Finland. In: Bulpitt C (ed). Epidemiology of Hypertension, Hypertension Handbook. Elsevier Science B.V Amsterdam 2000, pp 633–644.

  19. Gudmundsson LS, Johannsson M, Thorgeirsson G, Sigfusson N, Sigvaldason H, Witteman JC . Risk profiles and prognosis of treated and untreated hypertensive men and women in a population-based longitudinal study: the Reykjavik Study. J Hum Hypertens 2004; 18: 615–622.

    Article  CAS  Google Scholar 

  20. Kastarinen MJ, Antikainen RL, Laatikainen TK, Salomaa VV, Tuomilehto JO, Nissinen AM et al. Trends in hypertension care in eastern and south-western Finland during 1982–2002. J Hypertens 2006; 24: 829–836.

    Article  CAS  Google Scholar 

  21. Kastarinen M, Laatikainen T, Salomaa V, Jousilahti P, Antikainen R, Tuomilehto J et al. Trends in lifestyle factors affecting blood pressure in hypertensive and normotensive Finns during 1982–2002. J Hypertens 2007; 25: 299–305.

    Article  CAS  Google Scholar 

  22. Kastarinen M, Tuomilehto J, Vartiainen E, Jousilahti P, Sundvall J, Puska P et al. Trends in lipid levels and hypercholesterolemia in hypertensive and normotensive Finnish adults from 1982 to 1997. J Intern Med 2000; 247: 53–62.

    Article  CAS  Google Scholar 

  23. Kastarinen MJ, Nissinen AM, Vartiainen EA, Jousilahti PJ, Korhonen HJ, Puska PM et al. Blood pressure levels and obesity trends in hypertensive and normotensive Finnish population from 1982 to 1997. J Hypertens 2000; 18: 255–262.

    Article  CAS  Google Scholar 

  24. Antikainen RL, Moltchanov VA, Chukwuma Sr C, Kuulasmaa KA, Marques-Vidal PM, Sans S et al. WHO MONICA Project. Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project. Eur J Cardiovasc Prev Rehabil 2006; 13: 13–29.

    PubMed  Google Scholar 

  25. Kastarinen MJ, Salomaa VV, Vartiainen EA, Jousilahti PJ, Tuomilehto JO, Puska PM et al. Trends in blood pressure levels and control of hypertension in Finland from 1982 to 1997. J Hypertens 1998; 16: 1379–1387.

    Article  CAS  Google Scholar 

  26. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991. Hypertension 1995; 26: 60–69.

    Article  CAS  Google Scholar 

  27. Ribacke M, Tibblin G, Rosengren A, Eriksson H . Is hypertension changing? Blood pressure development in cohorts of 50-year-old men between 1963 and 1993. Blood Press 1996; 5: 134–138.

    Article  CAS  Google Scholar 

  28. Kastarinen MJ, Puska PM, Korhonen MH, Mustonen JN, Salomaa VV, Sundvall JE et al. Non-pharmacological treatment of hypertension in primary health care: a 2-year open randomized controlled trial of lifestyle intervention against hypertension in eastern Finland. J Hypertens 2002; 20: 2505–2512.

    Article  CAS  Google Scholar 

  29. Yosefy C, Dicker D, Viskoper JR, Tulchinsky TH, Ginsberg GM, Leibovitz E et al. The Ashkelon Hypertension Detection and Control Program (AHDC Program): a community approach to reducing cardiovascular mortality. Prev Med 2003; 37: 571–576.

    Article  CAS  Google Scholar 

  30. Guidelines Subcommittee. 2003 European Society of Hypertension European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053.

    Article  Google Scholar 

  31. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003; 289: 2560–2572.

    Article  Google Scholar 

  32. Kiiskinen U, Vartiainen E, Puska P, Aromaa A . Long-term cost and life-expectancy consequences of hypertension. J Hypertens 1998; 16: 1103–1101.

    Article  CAS  Google Scholar 

  33. Nilsson PM, Engström G, Hedblad B . Long-term predictors of increased mortality risk in screened men with new hypertension; the Malmo preventive project. J Hypertens 2008; 26: 2288–2294.

    Article  CAS  Google Scholar 

  34. Staessen JA, Thijs L, Fagard R, Celis H, Birehäger WH, Bulpitt CJ et al. Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J Hypertens 2004; 22: 1–11.

    Article  Google Scholar 

  35. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C . Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens 2006; 19: 243–250.

    Article  Google Scholar 

Download references

Acknowledgements

This paper was supported by a grant of the Finnish Foundation of Cardiovascular Research, the Academy of Finland (Grant no. 119681 and the EVO funds from the city of Oulu, Finland.

Author information

Authors and Affiliations

  1. Department of Public Health, University of Helsinki, Helsinki, Finland

    N C Barengo & J Tuomilehto

  2. Unit of Epidemiology and Clinical Research, University Hospital La Paz, Madrid, Spain

    N C Barengo

  3. Department of Internal Medicine, Kuopio University Hospital, Kuopio, Finland

    M Kastarinen

  4. Oulu City Hospital, Oulu, Finland

    R Antikainen

  5. Division of Medicine, Imperial College, London, UK

    R Antikainen

  6. Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, Finland

    A Nissinen

  7. South Ostrobothnia Central Hospital, Seinäjoki, Finland

    J Tuomilehto

Authors
  1. N C Barengo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Kastarinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Antikainen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Nissinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Tuomilehto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N C Barengo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barengo, N., Kastarinen, M., Antikainen, R. et al. The effects of awareness, treatment and control of hypertension on cardiovascular and all-cause mortality in a community-based population. J Hum Hypertens 23, 808–816 (2009). https://doi.org/10.1038/jhh.2009.30

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2009.30

Keywords

This article is cited by

Search

Advanced search

Quick links